Integrated analysis underlines etanercept efficacy in psoriasis
May 1, 2004
Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.
